DA-Raf, a dominant-negative antagonist of the Ras–ERK pathway, is a putative tumor suppressor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DA-Raf, a dominant-negative antagonist of the Ras–ERK pathway, is a putative tumor suppressor

Published:2018-01 Issue:1 Volume:362 Page:111-120
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Kanno Emiri,Kawasaki Osamu,Takahashi Kazuya,Takano Kazunori,Endo Takeshi

Funder

JSPS KAKENHI

MEXT KAKENHI

Intramural Research Grant

Mitsubishi Foundation

Uehara Memorial Foundation

Takeda Science Foundation

Publisher

Elsevier BV

Subject

Cell Biology

Reference46 articles.

1. RAS oncogenes: the first 30 years;Malumbres;Nat. Rev. Cancer,2003

2. Signaling interplay in Ras superfamily function;Mitin;Curr. Biol.,2005

3. Ras history: the saga continues;Cox;Small GTPases,2010

4. Deciphering the RAS/ERK pathway in vivo;Dorard;Biochem. Soc. Trans.,2017

5. Drugging the undruggable RAS: mission possible?;Cox;Nat. Rev. Drug Discov.,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MEK inhibitors and DA‐Raf, a dominant‐negative antagonist of the Ras–ERK pathway, prevent the migration and invasion of KRAS‐mutant cancer cells;Cytoskeleton;2024-06-14

2. The role of alternative splicing in lung cancer;Cancer Chemotherapy and Pharmacology;2023-06-19

3. From targeted therapy to a novel way: Immunogenic cell death in lung cancer;Frontiers in Medicine;2022-12-23

4. DA-Raf and the MEK inhibitor trametinib reverse skeletal myocyte differentiation inhibition or muscle atrophy caused by myostatin and GDF11 through the non-Smad Ras–ERK pathway;The Journal of Biochemistry;2021-10-22

5. M-Ras is Muscle-Ras, Moderate-Ras, Mineral-Ras, Migration-Ras, and Many More-Ras;Experimental Cell Research;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3